New Ivermectin Study Demonstrates 92 Percent Reduction in COVID-19 Mortality Rate
A new peer-reviewed study concluded that the mortality rate in people who used ivermectin regularly was 92 percent lower than in non-users and 84 percent lower than in irregular users.
Among the authors are Flávio Cadegiani, a board-certified endocrinologist, and Pierre Kory, an outspoken pulmonary and critical care medicine specialist, as well as president and chief medical officer of the Front Line Critical Care Alliance.
The study, published on Aug. 31 in the Cuerus Journal of Medical Science, was conducted via a prospective observational study of a “strictly controlled population” of 88,012 subjects in the Brazilian city of Itajaí.
The individuals that took ivermectin as a preventive medicine prior to COVID infection saw remarkable reductions in hospitalization as well as death, according to the publication.
The citywide program ran through July 7 and Dec. 2 of 2020, and was collected prospectively and systematically.
The method involved giving a smaller dose of ivermectin (proportional to body weight) for 150 days to a group considered the “irregular” group and up to three times or more of that dosage to the “regular” group.
Comparisons were made between non-users (subjects who did not use ivermectin), and regular and irregular users after multivariate adjustments. The full city database was used to calculate and compare COVID-19 infection and the risk of dying from COVID-19. The COVID-19 database was used and propensity score matching (PSM) was employed for hospitalization and mortality rates,” the study states.
In addition, the study asserts that the hospitalization rate was reduced by 100 percent in the “regular” group.
McCullough and Zelenko Protocols
Dr. Benjamin Marble, an urgent care specialist in Florida who has been practicing for over two decades, asserts that he and his group have treated about 150,000 acute COVID-19 patients and have only lost 6 people.
The nearly 100 percent effectiveness was achieved, Marble says, using the “McCullough protocol” (pdf) of which ivermectin is the cornerstone drug.
“This is another great study which proves ivermectin works against COVID-19, something I already knew is a simple fact,” Marble told The Epoch Times.
Marble thinks that this study “should be the nail in the coffin” to the claims that ivermectin does not help against COVID.
Kevin Jenkins, the co-chair of the Zelenko Foundation said: “This study proves what we have known for some time, that ivermectin was an effective tool to combat COVID-19.”
“Sadly, the only thing that comes to my mind is the lives that we’ve lost,” Jenkins told The Epoch Times.
Dr. Vladimir Zelenko is a Nobel prize-nominated physician who famously discovered and used an early treatment for COVID, dubbed the “Zelenko Protocol.” He passed away from cancer on June 30.
The “Zelenko Protocol” is a combination of hydroxychloroquine, ivermectin, zinc, azithromycin, and other drugs, including steroids.
more at THE EPOCHTIMES
